Epigenetic histone acetylation and Bdnf dysregulation in the hippocampus of rats exposed to repeated, low-dose diisopropylfluorophosphate

Life Sci. 2021 Sep 15:281:119765. doi: 10.1016/j.lfs.2021.119765. Epub 2021 Jun 26.

Abstract

Aims: Deployment-related exposures to organophosphate (OP) compounds are implicated for Gulf War Illness (GWI) development in First GW veterans. However, reasons for the persistence of GWI are not fully understood. Epigenetic modifications to chromatin are regulatory mechanisms that can adaptively or maladaptively respond to external stimuli. These include DNA methylation and histone acetylation. DNA methylation changes have been reported in GWI but the role of histone acetylation in GWI has been less explored, despite its importance as an epigenetic mechanism for neurological disorders.

Main methods: Male Sprague-Dawley rats were exposed to OP diisopropyl fluorophosphate (DFP, 0.5 mg/kg s.c., 5-d) and 6-m later brains were dissected for hippocampus. Western blotting, activity assays and chromatin immunoprecipitation (ChIP) were utilized for epigenetic analyses. Behavior was assessed using the Forced Swim Test (FST) and the Elevated Plus Maze (EPM).

Key findings: We observed a significant upregulation in HDAC1 protein along with a significant increase in HDAC enzyme activity in the hippocampus of DFP rats. A locus-specific ChIP study revealed decreases in H3K9ac at the brain derived neurotrophic factor (Bdnf) promoter IV coupled with a significant decrease in BDNF protein in DFP rat hippocampus. Treatment with HDAC inhibitor valproic acid reduced HDAC activity and decreased the FST immobility time in DFP rats.

Significance: Our research suggests that epigenetic alterations to histone acetylation pathways and decreased BDNF expression could represent novel mechanisms for GWI symptomatology and may provide new targets for developing effective drugs for GWI treatment.

Keywords: BDNF; DFP; Depression; Histone deacetylase; Histones; Organophosphates; Sprague-Dawley rats; Valproic acid.

MeSH terms

  • Acetylation
  • Animals
  • Brain-Derived Neurotrophic Factor / genetics*
  • Dose-Response Relationship, Drug
  • Epigenesis, Genetic*
  • Gene Expression Regulation / drug effects*
  • Hippocampus / drug effects*
  • Hippocampus / metabolism
  • Histone Deacetylase Inhibitors / pharmacology
  • Histones / metabolism*
  • Isoflurophate / administration & dosage*
  • Male
  • Promoter Regions, Genetic
  • Rats
  • Rats, Sprague-Dawley
  • Valproic Acid / pharmacology

Substances

  • Bdnf protein, rat
  • Brain-Derived Neurotrophic Factor
  • Histone Deacetylase Inhibitors
  • Histones
  • Isoflurophate
  • Valproic Acid